The FDA, under fire for sluggishness in approving generic drugs, announced this week that it had OKed a generic version of the popular nasal spray Flonase. In response, the drug's maker, GlaxoSmithKline, took legal action to halt the move. Helen Palmer reports from the Health Desk at WGBH.